Cargando…

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity

The aim of this study was to investigate initiation of and persistence with warfarin treatment in patients with atrial fibrillation (AF) according to ethnicity. Patients hospitalized with first-time AF from 1997 to 2009, prescription claims of warfarin and country of birth were identified by individ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Carolina Malta, Olesen, Jonas Bjerring, Hansen, Morten Lock, Azimi, Aziza, Torp-Pedersen, Christian, Dominguez, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385210/ https://www.ncbi.nlm.nih.gov/pubmed/22754529 http://dx.doi.org/10.3389/fphar.2012.00123

Ejemplares similares

Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2013)

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2015)

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
por: Lamberts, Morten, et al.
Publicado: (2017)

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
por: Selmer, Christian, et al.
Publicado: (2012)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013)

New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study
por: Selmer, Christian, et al.
Publicado: (2013)

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
por: Olesen, Jonas Bjerring, et al.
Publicado: (2011)

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study
por: Lindhardsen, Jesper, et al.
Publicado: (2012)

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
por: Staerk, Laila, et al.
Publicado: (2016)

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2018)

Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study
por: Ebbesen, Magnus N., et al.
Publicado: (2021)

Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study
por: Jakobsen, Christina Boegh, et al.
Publicado: (2019)

Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011
por: Hansen, Peter Wæde, et al.
Publicado: (2018)

Comparative thromboembolic risk in atrial fibrillation with and without a secondary precipitant—Danish nationwide cohort study
por: Gundlund, A, et al.
Publicado: (2019)

Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study
por: Gundlund, Anna, et al.
Publicado: (2016)

Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort
por: Gundlund, Anna, et al.
Publicado: (2018)

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis
por: Ruwald, Martin Huth, et al.
Publicado: (2013)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
por: Laugesen, Emma Kirstine, et al.
Publicado: (2019)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Risk Prediction of Atrial Fibrillation Based on Electrocardiographic Interatrial Block
por: Skov, Morten W., et al.
Publicado: (2018)

Prognostic importance of atrial fibrillation in heart failure according to time elapsed since diagnosis
por: Schwartz, Brian, et al.
Publicado: (2022)

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
por: Staerk, Laila, et al.
Publicado: (2015)

Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2021)

Atrial fibrillation onset before heart failure or vice versa: what is worst? A nationwide register study
por: Pallisgaard, Jannik, et al.
Publicado: (2022)

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2017)

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
por: LaHaye, Stephen Andrew, et al.
Publicado: (2012)

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
por: Halvorsen, Sigrun, et al.
Publicado: (2014)

Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study
por: Tønnesen, Jacob, et al.
Publicado: (2022)

Protocol for detecting unrecognized sleep apnea in patients with atrial fibrillation by a home-monitoring device: the DAN-APNO study
por: Jensen, Mads Hashiba, et al.
Publicado: (2022)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Prevalence of sleep apnea in unselected patients with atrial fibrillation by a home-monitoring device: The DAN-APNO study
por: Jensen, Mads Hashiba, et al.
Publicado: (2023)

Atrial fibrillation—a complex polygenetic disease
por: Andersen, Julie H., et al.
Publicado: (2020)

Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation
por: Vinding, Naja E., et al.
Publicado: (2022)

Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
por: Coleman, Craig I., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jeukfb2m8u09bpo5kl86tn7bcg